Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

Caocci G.;Mulas O.;Capodanno I.;Abruzzese E.;Iurlo A.;Luciano L.;Albano F.;Annunziata M.;Tiribelli M.;Bonifacio M.;Galimberti S.;Castagnetti F.;Sgherza N.;Stagno F.;Gozzini A.;Orlandi E. M.;Luzi D.;Binotto G.;Pregno P.;Fozza C.;Efficace F.;Simula M. P.;Trawinska M. M.;Cattaneo D.;De Gregorio F.;Attolico I.;Stella R.;Scaffidi L.;Barate C.;Gugliotta G.;Scalzulli E.;Elena C.;Pirillo F.;Foa R.;Breccia M.;Nasa G. L.

2020-01-01